angiotensin ii has been researched along with Renal Insufficiency, Chronic in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (2.74) | 29.6817 |
2010's | 54 (73.97) | 24.3611 |
2020's | 17 (23.29) | 2.80 |
Authors | Studies |
---|---|
Alenina, N; Bader, M; Clahsen-van Groningen, MC; Danser, AHJ; Essers, J; Garrelds, IM; Qadri, F; Ridwan, Y; Roks, AJM; van der Linden, J; van der Pluijm, I; van Thiel, BS; Vermeij, M | 1 |
Bethea, JR; Drummer, C; Hu, W; Jiang, X; Kunapuli, SP; Lu, Y; Saaoud, F; Shao, Y; Sun, J; Sun, Y; Vazquez-Padron, RI; Wang, H; Wu, S; Xu, K; Yang, X; Yu, J | 1 |
Berghaus, RD; Brown, SA; Coleman, AE; Lourenço, BN; Schmiedt, CW; Tarigo, JL | 1 |
Pao, AC; Raphael, KL; Ravikumar, NPG | 1 |
Chen, Z; Ding, G; Feng, J; Hu, J; Liang, W; Luo, Q; Luo, Z; Yang, H; Zhang, Z; Zhu, Z | 1 |
Fogo, AB; Ma, LJ; Matsushita, K; Wang, J; Yang, HC; Zhong, J | 1 |
Chen, Z; Ding, G; Feng, J; Hao, Y; Hu, J; Huang, X; Liang, W; Luo, Z; Yang, X; Zhang, Z; Zhu, Z | 1 |
Alirezaei, A; Argani, H; Ghorbanihaghjo, A; Jabarpour, M; Panah, F; Ranjbarzadhag, M; Rashtchizadeh, N; Sanajou, D | 1 |
Beer Stolz, D; Cerqueira, DM; Fu, H; Ho, J; Li, Y; Liu, Y; Rush, BM; Tan, RJ; Zhou, D | 1 |
Bushinsky, DA; Buysse, JM; Wesson, DE | 1 |
Chen, P; Cheng, Q; Huo, C; Li, J; Liu, J; Lu, L; Miao, N; Ni, J; Xie, H; Xu, D; Yin, F; Yu, C; Zhang, W; Zhang, Y; Zheng, P; Zhou, L; Zhou, Z | 1 |
Antlanger, M; Berlakovich, G; Böhmig, GA; Domenig, O; Eskandary, F; Fajkovic, H; Grobe, N; Gruber, C; Hellinger, R; Kain, R; Kaltenecker, CC; Kopecky, C; Kovarik, JJ; Poglitsch, M; Rahman, M; Säemann, MD; Stegbauer, J | 1 |
Gan, H; He, J; Li, C; Xia, W; Xia, Y; Zhao, H; Zhong, X | 1 |
Chen, Z; Ding, G; Feng, J; Hu, J; Liang, W; Wang, H; Yang, D; Yang, Q; Yang, Y; Zhu, Z | 1 |
Lu, K; Shi, C; Xia, H; Zhang, B; Zhang, P | 1 |
Benetti, A; Girardi, ACC; Luchi, WM; Martins, FL; Seguro, AC; Sene, LB; Shimizu, MHM | 1 |
Fujita, Y; Hoshino, S; Ichikawa, D; Inoue, K; Kamijo-Ikemori, A; Kimura, K; Ohata, K; Shibagaki, Y; Sugaya, T; Tanabe, J; Togo, T; Watanabe, M | 1 |
Bovée, DM; Clahsen-van Groningen, MC; Danser, AHJ; Domenig, O; Foster, D; Garrelds, IM; Hoorn, EJ; Huang, S; Kim, JB; Lu, X; Melton, L; Poglitsch, M; Ren, L; Uijl, E; van Veghel, R; Zlatev, I | 1 |
Hoang, T; Revoori, R; Rianto, F; Sparks, MA | 1 |
Qian, J; Sun, B; Wang, H; Xing, C; Zhao, X | 1 |
Gan, X; Lu, L; Miao, N; Shen, Y; Wang, B; Xu, D; Xu, J; Xue, H; Yang, L; Zhang, W; Zhou, L | 1 |
Beanlands, RS; Burns, KD; Croteau, E; DaSilva, JN; deKemp, RA; Hadizad, T; Ismail, B | 1 |
Armeni, A; Cerantonio, A; Fuiano, G; Simeoni, M; Summaria, C | 1 |
Ding, G; Ma, Y; Yang, J; Yang, Q; Yang, Y | 1 |
Pruszynski, J; Roehm, B; Simoni, J; Wesson, DE | 1 |
Cechova, S; Chan, F; Dong, F; Kelley, MJ; Le, TH; Ruiz, P | 1 |
Kraut, JA; Madias, NE | 1 |
Andrew, R; Freel, EM; Homer, NZM; Jardine, AG; Mark, PB; McQuarrie, EP; Rankin, AJ; Taylor, AHM | 1 |
Beddhu, S; Huang, Y; Tang, L; Tian, M; Wu, Y | 1 |
Hitomi, H; Kitabayashi, C; Kobara, H; Kobori, H; Konishi, Y; Li, L; Masaki, T; Morikawa, T; Nakano, D; Nishiyama, A; Zhang, Y | 1 |
Chen, L; Feng, Y; Gan, H; Haydon, RC; He, TC; Huang, B; Huang, S; Lei, J; Liu, W; Luo, W; Luu, HH; Shu, Y; Wang, X; Xia, Y; Yan, S; Yu, X; Yuan, C; Zeng, L; Zeng, Z; Zhang, B; Zhang, H; Zhang, L; Zhang, R; Zhang, X; Zhao, C | 1 |
Cai, H; Chen, S | 1 |
Ban, TH; Chang, YS; Choi, BS; Jang, IA; Kim, EN; Kim, MY; Lim, JH; Park, CW; Yoon, HE | 1 |
Chen, B | 1 |
Ichikawa, H; Kimura, Y; Narita, I; Narita, M; Okumura, K; Osanai, T; Shimada, M; Tanaka, M; Tomita, H | 1 |
Arruda-Junior, DF; Benetti, A; Beraldo, JI; Borges-Júnior, FA; Dariolli, R; Girardi, ACC; Jensen, L; Luchi, WM; Martins, FL; Seguro, AC; Shimizu, MH | 1 |
Fang, F; Kim, C; Liu, GC; Scholey, JW; Yassa, R; Zhou, J | 1 |
Akakabe, Y; Ikeda, K; Irie, D; Kato, T; Kawahito, H; Kishida, S; Matoba, S; Matsubara, H; Mori, Y; Ogata, T; Takata, H; Ueyama, T; Wakana, N; Yamada, H | 1 |
Ding, W; Gu, Y; Xu, C; Zhang, M | 1 |
Ding, XQ; Lv, WL; Teng, J; Zhang, XY; Zhong, YH | 1 |
Čertíková Chábová, V; Červenka, L; Hammock, BD; Husková, Z; Hwang, SH; Imig, JD; Kitada, K; Kompanowska-Jezierska, E; Kramer, HJ; Kujal, P; Nishiyama, A; Sadowski, J; Škaroupková, P; Vernerová, Z; Walkowska, A | 1 |
Xu, B; Xu, C; Xu, Z | 1 |
Manucha, W | 1 |
Crowley, SD; Griffiths, R; Jin, H; Karlovich, NS; Lin, EE; Mao, A; Patel, MB; Song, YS; Sparks, MA; Wu, M; Zhang, J | 1 |
Chen, X; Dickhout, JG; Gao, B; Krepinsky, JC; Li, R; Lu, C; Mohammed-Ali, Z; Wang, TN; Yum, V | 1 |
Re, RN | 2 |
Farnham, MM; Hildreth, CM; Phillips, JK; Pilowsky, PM; Saha, M; Sun, QJ; Yao, Y | 1 |
Asare, Y; Bruck, H; Heinze, G; Jankowski, J; Jankowski, V; Liehn, E; Machado, FB; Marx, N; Muñoz-Castañeda, JR; Pineda-Martos, C; Raya-Bermudez, A; Rodriguez, M; Salem, S; Staudt, M; Welker, P; Zidek, W | 1 |
Ikeda, H; Kitazono, T; Noguchi, H; Suehiro, T; Tokumoto, M; Toyonaga, J; Tsuruya, K; Yamada, S | 1 |
Eltzschig, HK; Grenz, A; Jin, J; Kellems, RE; Luo, R; Tao, L; Wu, H; Xia, Y; Zhang, W; Zhang, Y; Zhao, C | 1 |
Ask, K; Carlisle, RE; Cruz, GL; Dickhout, JG; Lu, C; Mohammed-Ali, Z; Werner, KE | 1 |
Azegami, T; Hayashi, K; Itoh, H; Nakamura, M; Oguchi, H; Sakamaki, Y; Sasamura, H; Tokuyama, H; Wakino, S | 1 |
Basile, DP; Collett, JA; Ivancic, CM; Mehrotra, P; Patel, JB | 1 |
Alvarez-Prats, A; Baranova, IN; Bocharov, AV; Eggerman, TL; Hu, X; Huang, YG; Mullick, AE; Patterson, AP; Remaley, AT; Souza, AC; Star, RA; Street, JM; Vishnyakova, TG; Wilkins, KJ; Yuen, PS | 1 |
Diedrich, A; Finney, C; Harris, RC; Kloepfer, LA; Zeng, F | 1 |
Ask, K; Carlisle, RE; Dickhout, JG; Krepinsky, JC; Lu, C; Lukic, D; Marway, MK; Mohammed-Ali, Z | 1 |
Chen, C; Han, Q; Liang, W; Luo, Z; Lv, X; Su, K; Wang, Y; Yan, M; Zeng, P | 1 |
Delafontaine, P; Du, J; Garcia, G; Han, G; Hu, Z; Mitch, WE; Zhang, L | 1 |
Macconi, D | 1 |
Edwards, NC; Ferro, CJ; Hammer, F; Hughes, BA; Steeds, RP; Stewart, PM; Townend, JN | 1 |
Ahn, SY; Ahn, YM; Chung, JH; Kang, SW; Kim, SD; Kim, SK; Lee, BC; Lee, SH | 1 |
Kagami, S; Kondo, S; Urushihara, M | 1 |
Blackburn, MR; Dai, Y; Kellems, RE; Ning, C; Sun, H; Tao, L; Wang, W; Xia, Y; Yu, H; Zhang, W; Zhang, Y | 1 |
Nishiyama, A | 1 |
Amaram, JS; Hillerson, D; Raizada, V; Skipper, B | 1 |
Baucke, J; Danser, AH; Divac, N; Fraune, C; Frenay, AR; Garrelds, IM; Hölzel, A; Jankowski, V; Krebs, C; Lange, S; Nguyen, G; Schwedhelm, E; Stahl, R; Streichert, T; van Goor, H; Velden, J; Wenzel, UO | 1 |
Dejima, T; Maeda, A; Mitsuhashi, H; Tamura, K; Tokita, Y; Tsurumi-Ikeya, Y; Umemura, S; Uneda, K; Wakui, H; Yamaguchi, S | 1 |
Mitani, S; Taniguchi, K; Yabuki, A; Yamato, O | 1 |
Avinash Raj, T; Kalai Gana Selvi, S; Kaliappan, G; Mahesh Kumar, J; Moorthy, R; Nagarajan, P | 1 |
Bidani, AK; Griffin, KA; Loutzenhiser, R; Polichnowski, AJ | 1 |
de Borst, MH; Mirković, K | 1 |
Fujigaki, Y; Fukasawa, H; Hishida, A; Kato, A; Nakagawa, T; Nakamura, Y; Ohashi, N; Suzuki, F; Suzuki, H; Yamamoto, T | 1 |
13 review(s) available for angiotensin ii and Renal Insufficiency, Chronic
Article | Year |
---|---|
Acid-Mediated Kidney Injury Across the Spectrum of Metabolic Acidosis.
Topics: Acidosis; Aldosterone; Ammonium Compounds; Angiotensin II; Citrates; Endothelin-1; Humans; Kidney; Renal Insufficiency, Chronic | 2022 |
The impact of dyslipidemia and oxidative stress on vasoactive mediators in patients with renal dysfunction.
Topics: Angiotensin II; Dyslipidemias; Endothelin-1; Humans; Nitric Oxide; Oxidative Stress; Proprotein Convertase 9; Renal Insufficiency, Chronic | 2019 |
Angiotensin receptors in the kidney and vasculature in hypertension and kidney disease.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Gene Expression Regulation; Humans; Hypertension; Kidney Tubules, Proximal; Mice; Mice, Knockout; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Insufficiency, Chronic; Renin-Angiotensin System; Signal Transduction; Water-Electrolyte Balance | 2021 |
Current evidence on the use of anti-RAAS agents in congenital or acquired solitary kidney.
Topics: Adult; Age Factors; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Child; Disease Progression; Female; Humans; Hypertension; Kidney; Male; Protective Agents; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Renin-Angiotensin System; Sex Factors; Solitary Kidney | 2017 |
Retarding progression of chronic kidney disease: use of modalities that counter acid retention.
Topics: Acid-Base Imbalance; Aldosterone; Angiotensin II; Animals; Buffers; Citrates; Dietary Proteins; Disease Progression; Endothelins; Fibrosis; Fruit; Humans; Kidney; Renal Insufficiency, Chronic; Sodium Bicarbonate; Sodium Citrate; Vegetables | 2018 |
[Mitochondria and oxidative stress participation in renal inflammatory process].
Topics: Angiotensin II; Animals; Apoptosis; Cytoprotection; Ergocalciferols; Humans; Kidney Cortex; Kidney Tubules; Mitochondria; Nephritis; NF-kappa B; Oxidative Stress; Renal Insufficiency, Chronic; Vitamins | 2014 |
A possible mechanism for the progression of chronic renal disease and congestive heart failure.
Topics: Angiotensin II; Disease Progression; Heart Failure; Humans; Neurodegenerative Diseases; Renal Insufficiency, Chronic; Renin-Angiotensin System; Up-Regulation | 2015 |
An Expanded View of Progressive Cardiorenal Disorders.
Topics: Angiotensin II; Angiotensinogen; Cardio-Renal Syndrome; Disease Progression; Heart Failure; Humans; Parathyroid Hormone-Related Protein; Peptidyl-Dipeptidase A; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Signal Transduction; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2016 |
Targeting the renin angiotensin system for remission/regression of chronic kidney disease.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Nephropathies; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Humans; Hypertension, Renal; Models, Biological; Proteinuria; Remission Induction; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2010 |
[Progress of pediatric nephrology].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antibodies, Monoclonal, Murine-Derived; Biomarkers; Child; Clinical Trials as Topic; Early Diagnosis; Humans; Immunologic Factors; Kidney; Losartan; Mutation; Myosin Heavy Chains; Nephrotic Syndrome; Nerve Tissue Proteins; Renal Insufficiency, Chronic; Rituximab; Urinary Tract | 2011 |
[Mechanisms responsible for the renoprotective effects of renin-angiotensin inhibitors].
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Humans; Hypertension; Kidney; Mineralocorticoid Receptor Antagonists; Rats; Receptors, Mineralocorticoid; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2012 |
Angiotensin II-mediated left ventricular abnormalities in chronic kidney disease.
Topics: Aldosterone; Angiotensin II; Animals; Heart Ventricles; Humans; Renal Insufficiency, Chronic; Ventricular Dysfunction, Left | 2012 |
Renal microvascular dysfunction, hypertension and CKD progression.
Topics: Angiotensin II; Blood Pressure; Disease Progression; Homeostasis; Humans; Hypertension, Renal; Kidney Glomerulus; Microvessels; Nitric Oxide; Renal Insufficiency, Chronic | 2013 |
4 trial(s) available for angiotensin ii and Renal Insufficiency, Chronic
Article | Year |
---|---|
Cigarette Smoking Attenuates Kidney Protection by Angiotensin-Converting Enzyme Inhibition in Nondiabetic Chronic Kidney Disease.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cigarette Smoking; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Oxidative Stress; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Smoking Cessation | 2017 |
Non-uniform relationship between salt status and aldosterone activity in patients with chronic kidney disease.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Cross-Over Studies; Diet, Sodium-Restricted; Humans; Hypertension; Middle Aged; Renal Insufficiency, Chronic; Renin-Angiotensin System; Sodium Chloride, Dietary; Vasoconstrictor Agents; Young Adult | 2018 |
The effect of spironolactone upon corticosteroid hormone metabolism in patients with early stage chronic kidney disease.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Female; Humans; Hydrocortisone; Kidney Failure, Chronic; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Renal Insufficiency, Chronic; Renin; Spironolactone; Tetrahydrocortisol | 2010 |
Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensinogen; Antihypertensive Agents; Biomarkers; Collagen Type I; Female; Humans; Kidney; Losartan; Male; Middle Aged; Renal Insufficiency, Chronic | 2007 |
56 other study(ies) available for angiotensin ii and Renal Insufficiency, Chronic
Article | Year |
---|---|
In Vivo Renin Activity Imaging in the Kidney of Progeroid
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; DNA Damage; DNA Repair; DNA-Binding Proteins; Endonucleases; Female; Gene Expression Regulation; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Losartan; Male; Mice; Mice, Knockout; Progeria; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Signal Transduction | 2021 |
Aorta in Pathologies May Function as an Immune Organ by Upregulating Secretomes for Immune and Vascular Cell Activation, Differentiation and Trans-Differentiation-Early Secretomes may Serve as Drivers for Trained Immunity.
Topics: Angiotensin II; Aorta; Caspase 1; Cell Differentiation; Cell Transdifferentiation; COVID-19; Cytokines; Endothelial Cells; Humans; Middle East Respiratory Syndrome Coronavirus; NF-E2-Related Factor 2; Renal Insufficiency, Chronic; Secretome | 2022 |
Characterization of the intrarenal renin-angiotensin system in cats with naturally occurring chronic kidney disease.
Topics: Angiotensin II; Animals; Cat Diseases; Cats; Kidney; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System | 2022 |
Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacement.
Topics: Anaerobiosis; Angiotensin II; Animals; Diabetic Nephropathies; Glycolysis; Mice; Podocytes; Pyruvate Kinase; Renal Insufficiency, Chronic | 2023 |
Low-Dose Erythropoietin Amplifies Beneficial Effects of Angiotensin II Blockade on Glomerulosclerosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Creatinine; Endothelial Cells; Erythropoietin; Mice; Proto-Oncogene Proteins c-akt; Renal Insufficiency, Chronic; Vascular Endothelial Growth Factor A | 2023 |
PFKFB3 downregulation aggravates Angiotensin II-induced podocyte detachment.
Topics: Angiotensin II; Animals; Down-Regulation; Mice; Phosphofructokinase-2; Phosphorylation; Podocytes; Renal Insufficiency, Chronic | 2023 |
Tubular injury triggers podocyte dysfunction by β-catenin-driven release of MMP-7.
Topics: Angiotensin II; Animals; beta Catenin; Cells, Cultured; Disease Models, Animal; Doxorubicin; Humans; Kidney Tubules; Male; Matrix Metalloproteinase 7; Membrane Proteins; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Podocytes; Primary Cell Culture; Proteolysis; Rats; Renal Insufficiency, Chronic | 2019 |
Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.
Topics: Acid-Base Equilibrium; Acidosis; Adaptation, Physiological; Aldosterone; Angiotensin II; Biomarkers; Disease Progression; Endothelin-1; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Prospective Studies; Renal Insufficiency, Chronic; Retrospective Studies; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome | 2020 |
RIG-I aggravates interstitial fibrosis via c-Myc-mediated fibroblast activation in UUO mice.
Topics: Angiotensin II; Animals; Biomarkers; Biopsy; Cytokines; DEAD Box Protein 58; Disease Susceptibility; Fibroblasts; Fibrosis; Gene Silencing; Immunohistochemistry; Inflammation Mediators; Interleukin-1beta; Male; Mice; Proto-Oncogene Proteins c-myc; Renal Insufficiency, Chronic; Smad Proteins; Transforming Growth Factor beta; Ureteral Obstruction | 2020 |
Critical Role of Neprilysin in Kidney Angiotensin Metabolism.
Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Case-Control Studies; Chymases; Enzyme Inhibitors; Female; Humans; Kidney; Male; Mice, Inbred C57BL; Middle Aged; Neprilysin; Peptide Fragments; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2020 |
The CX3CL1/CX3CR1 axis is upregulated in chronic kidney disease and contributes to angiotensin II-induced migration of vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Cell Line; Cell Movement; Chemokine CX3CL1; CX3C Chemokine Receptor 1; Disease Models, Animal; Interleukin-6; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Proto-Oncogene Proteins c-akt; Renal Insufficiency, Chronic; Signal Transduction; Up-Regulation; Uremia | 2020 |
Sirt6 deficiency aggravates angiotensin II-induced cholesterol accumulation and injury in podocytes.
Topics: Adult; Angiotensin II; Animals; Anticholesteremic Agents; Biopsy; Case-Control Studies; Cell Line; Cholesterol; Datasets as Topic; Disease Models, Animal; Female; Gene Expression Profiling; Humans; Lipid Metabolism; Male; Mice; Mice, Knockout; Middle Aged; Oligonucleotide Array Sequence Analysis; Podocytes; Renal Insufficiency, Chronic; Sirtuins | 2020 |
Alteration and association between serum ACE2/ angiotensin(1-7)/Mas axis and oxidative stress in chronic kidney disease: A pilot study.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Angiotensin I; Angiotensin II; Case-Control Studies; Female; Humans; Male; Middle Aged; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Pilot Projects; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2020 |
Urinary DPP4 correlates with renal dysfunction, and DPP4 inhibition protects against the reduction in megalin and podocin expression in experimental CKD.
Topics: Angiotensin II; Animals; Biomarkers; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Fibrosis; Intracellular Signaling Peptides and Proteins; Kidney; Low Density Lipoprotein Receptor-Related Protein-2; Male; Membrane Proteins; Proteinuria; Rats, Wistar; Renal Insufficiency, Chronic; Retinol-Binding Proteins, Plasma; Signal Transduction; Sitagliptin Phosphate | 2021 |
Angiotensin II type 1a receptor loss ameliorates chronic tubulointerstitial damage after renal ischemia reperfusion.
Topics: Angiotensin II; Animals; Blood Pressure; Hydralazine; Ischemia; Kidney; Male; Mice; Mice, Knockout; Receptor, Angiotensin, Type 1; Renal Insufficiency, Chronic; Reperfusion | 2021 |
Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease.
Topics: Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Arterial Pressure; Captopril; Disease Models, Animal; Kidney; Liver; Losartan; Rats; Renal Insufficiency, Chronic; Renin-Angiotensin System; RNA, Small Interfering | 2021 |
β-Aminoisobutyric acid ameliorates the renal fibrosis in mouse obstructed kidneys via inhibition of renal fibroblast activation and fibrosis.
Topics: Aminoisobutyric Acids; Angiotensin II; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Extracellular Matrix; Fibroblasts; Fibrosis; Interleukin-17; Kidney; Male; Rats, Sprague-Dawley; Reactive Oxygen Species; Renal Insufficiency, Chronic; Signal Transduction | 2017 |
c-Myc promotes renal fibrosis by inducing integrin αv-mediated transforming growth factor-β signaling.
Topics: Angiotensin II; Animals; Extracellular Matrix; Fibroblasts; Fibrosis; Folic Acid; Integrin alphaV; Kidney; Male; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-myc; Renal Insufficiency, Chronic; Signal Transduction; Thiazoles; Transforming Growth Factor beta; Up-Regulation; Ureteral Obstruction | 2017 |
Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Diltiazem; Disease Progression; Enalapril; Gene Expression Regulation; Heart; Kidney; Male; Organ Size; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Regional Blood Flow; Renal Insufficiency, Chronic | 2017 |
Angiotensin II induces cholesterol accumulation and injury in podocytes.
Topics: Angiotensin II; Animals; Apoptosis; Cholesterol; Cytoskeleton; Disease Models, Animal; Gene Expression; Lipid Metabolism; Perilipin-2; Podocytes; Renal Insufficiency, Chronic; Simvastatin | 2017 |
Topics: Actins; Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Movement; Cells, Cultured; Disease Models, Animal; Genotype; Hypertension; Male; Mice; Mutation, Missense; Myosin Heavy Chains; Nephrectomy; Nonmuscle Myosin Type IIA; Podocytes; Primary Cell Culture; Renal Insufficiency, Chronic; Sodium Chloride, Dietary; Stress Fibers; Tetrazoles | 2018 |
Adiponectin attenuates kidney injury and fibrosis in deoxycorticosterone acetate-salt and angiotensin II-induced CKD mice.
Topics: Adiponectin; Angiotensin II; Animals; Cell Proliferation; Desoxycorticosterone Acetate; Disease Models, Animal; Fibrosis; Hepatitis A Virus Cellular Receptor 1; Kidney; Lipocalin-2; Low Density Lipoprotein Receptor-Related Protein-2; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidase 2; NADPH Oxidases; Nephrectomy; Receptors, Cell Surface; Renal Insufficiency, Chronic; Signal Transduction; Transcription Factor RelA; Up-Regulation | 2018 |
Effect of a SGLT2 inhibitor on the systemic and intrarenal renin-angiotensin system in subtotally nephrectomized rats.
Topics: Administration, Oral; Angiotensin II; Angiotensinogen; Animals; Disease Models, Animal; Glucosides; Glycosuria; Indoles; Kidney; Male; Nephrectomy; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2018 |
A blockade of PI3Kγ signaling effectively mitigates angiotensin II-induced renal injury and fibrosis in a mouse model.
Topics: Angiotensin II; Animals; Cell Proliferation; Class Ib Phosphatidylinositol 3-Kinase; Cytokines; Disease Models, Animal; Fibroblasts; Fibrosis; Kidney; Mice; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Quinoxalines; Renal Insufficiency, Chronic; Thiazolidinediones | 2018 |
Adiponection, a novel player to save the kidneys.
Topics: Acetates; Adiponectin; Angiotensin II; Animals; Desoxycorticosterone Acetate; Fibrosis; Mice; Renal Insufficiency, Chronic | 2018 |
Effects of Resveratrol on the Renin-Angiotensin System in the Aging Kidney.
Topics: Albuminuria; Angiotensin I; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Collagen Type IV; Fibronectins; Fibrosis; Kidney; Male; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Plant Extracts; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Renal Insufficiency, Chronic; Renin-Angiotensin System; Resveratrol; Superoxide Dismutase | 2018 |
The miRNA-184 drives renal fibrosis by targeting HIF1AN in vitro and in vivo.
Topics: Actins; Angiotensin II; Animals; Cell Line; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Databases, Genetic; Disease Models, Animal; Fibroblasts; Fibrosis; Humans; Kidney; Mice; MicroRNAs; Mixed Function Oxygenases; Rats; Renal Insufficiency, Chronic; RNA, Messenger; Ureteral Obstruction | 2019 |
Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor Pathway.
Topics: Albuminuria; Angiotensin II; Animals; Blood Coagulation; Factor Xa Inhibitors; Gene Knockdown Techniques; Glomerular Basement Membrane; Glomerular Mesangium; Humans; Hypertension; In Vitro Techniques; Inflammation; Kidney Glomerulus; Male; Mice; Mice, Transgenic; Podocytes; Receptor, PAR-2; Renal Insufficiency, Chronic; Renin; Reverse Transcriptase Polymerase Chain Reaction; Rivaroxaban; Vasoconstrictor Agents | 2019 |
Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Blood Pressure; Body Weight; Cardiotonic Agents; Diastole; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Kidney; Kidney Function Tests; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Rats, Wistar; Renal Insufficiency, Chronic; Renin-Angiotensin System; Sitagliptin Phosphate; Up-Regulation; Ventricular Remodeling | 2019 |
Adiponectin attenuates angiotensin II-induced oxidative stress in renal tubular cells through AMPK and cAMP-Epac signal transduction pathways.
Topics: Adiponectin; AMP-Activated Protein Kinases; Angiotensin II; Cells, Cultured; Cyclic AMP; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Fibronectins; Gene Expression; Guanine Nucleotide Exchange Factors; Humans; Kidney Tubules, Proximal; NADPH Oxidases; NF-kappa B; Oxidative Stress; Pyrazoles; Pyrimidines; Receptors, Adiponectin; Renal Insufficiency, Chronic; Renin-Angiotensin System; Signal Transduction | 2013 |
Periaortic adipose tissue-specific activation of the renin-angiotensin system contributes to atherosclerosis development in uninephrectomized apoE-/- mice.
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Angiotensinogen; Animals; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Cholesterol, Dietary; Disease Models, Animal; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephrectomy; PPAR gamma; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2013 |
Protective effects of angiotensin-(1-7) administrated with an angiotensin-receptor blocker in a rat model of chronic kidney disease.
Topics: Angiopoietins; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Fibronectins; Losartan; Male; Nephrectomy; Peptide Fragments; Plasminogen Activator Inhibitor 1; Rats, Sprague-Dawley; Receptor, TIE-2; Renal Insufficiency, Chronic; Systole | 2013 |
ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensinogen; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Male; Middle Aged; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regression Analysis; Renal Insufficiency, Chronic; Renin-Angiotensin System; Young Adult | 2013 |
Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.
Topics: Angiotensin II; Animals; Blood Pressure; Epoxide Hydrolases; Female; Hypertension; Nephrectomy; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renal Insufficiency, Chronic; Survival Rate | 2014 |
Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Angiotensinogen; Asian People; Biomarkers; China; Collagen Type IV; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Receptors, Angiotensin; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Young Adult | 2015 |
Tumor necrosis factor-α produced in the kidney contributes to angiotensin II-dependent hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Hypertension; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Renal Insufficiency, Chronic; Renin-Angiotensin System; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 2014 |
SREBP-1 Mediates Angiotensin II-Induced TGF-β1 Upregulation and Glomerular Fibrosis.
Topics: Angiotensin II; Animals; Cells, Cultured; Endoplasmic Reticulum Stress; ErbB Receptors; Fibronectins; Fibrosis; Intracellular Signaling Peptides and Proteins; Kidney; Male; Membrane Proteins; Mesangial Cells; Mice; Mice, Inbred C57BL; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Rats, Inbred Dahl; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Insufficiency, Chronic; Serine Proteases; Sp1 Transcription Factor; Sterol Regulatory Element Binding Protein 1; Thiazoles; Transforming Growth Factor beta1; Up-Regulation | 2015 |
The effect of losartan on differential reflex control of sympathetic nerve activity in chronic kidney disease.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Autonomic Pathways; Baroreflex; Kidney; Losartan; Lumbosacral Region; Male; Nitroprusside; Phenylephrine; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Renal Insufficiency, Chronic; Sympathetic Nervous System | 2015 |
Identification of the Vasoconstriction-Inhibiting Factor (VIF), a Potent Endogenous Cofactor of Angiotensin II Acting on the Angiotensin II Type 2 Receptor.
Topics: Adrenal Glands; Amino Acid Sequence; Angiotensin II; Animals; Cattle; Cells, Cultured; Chromogranin A; Endothelial Cells; Heart Failure; Humans; Male; MAP Kinase Signaling System; Mice; Molecular Sequence Data; p38 Mitogen-Activated Protein Kinases; Peptides; Protein Processing, Post-Translational; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Angiotensin, Type 2; Renal Insufficiency, Chronic; Renin-Angiotensin System; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vasodilation | 2015 |
Systemic Aldosterone, But Not Angiotensin II, Plays a Pivotal Role in the Pathogenesis of Renal Injury in Chronic Nitric Oxide-Deficient Male Rats.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Blood Pressure; Chemokine CCL2; Disease Models, Animal; Enzyme Inhibitors; Kidney; Macrophages; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Osteopontin; Rats; Renal Insufficiency, Chronic; Renin-Angiotensin System; RNA, Messenger; Time Factors; Transforming Growth Factor beta1 | 2015 |
Elevated Endothelial Hypoxia-Inducible Factor-1α Contributes to Glomerular Injury and Promotes Hypertensive Chronic Kidney Disease.
Topics: Angiotensin II; Animals; Antigens, CD; Cadherins; Cells, Cultured; Disease Progression; Endothelial Cells; Endothelin-1; Endothelium, Vascular; Feedback, Physiological; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Glomerulus; Mice; Mice, Transgenic; NF-kappa B; Organ Culture Techniques; Renal Insufficiency, Chronic; RNA, Small Interfering; Up-Regulation | 2015 |
Development of a Model of Chronic Kidney Disease in the C57BL/6 Mouse with Properties of Progressive Human CKD.
Topics: Angiotensin II; Animals; Desoxycorticosterone Acetate; Disease Models, Animal; Disease Progression; Female; Humans; Male; Mice; Renal Insufficiency, Chronic | 2015 |
Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cell Line; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Doxorubicin; Epigenesis, Genetic; Irbesartan; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Male; Membrane Proteins; Mice, Inbred C57BL; Mice, Knockout; Podocytes; Promoter Regions, Genetic; Renal Insufficiency, Chronic; Renin-Angiotensin System; Signal Transduction; Tetrazoles; Time Factors; Transfection | 2015 |
Th-17 cell activation in response to high salt following acute kidney injury is associated with progressive fibrosis and attenuated by AT-1R antagonism.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cells, Cultured; Cytoprotection; Disease Models, Animal; Disease Progression; Fibrosis; Kidney; Losartan; Lymphocyte Activation; Male; Nephrectomy; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Renin-Angiotensin System; Sodium Chloride, Dietary; Th17 Cells; Time Factors | 2015 |
Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation.
Topics: Angiotensin II; Animals; Blood Pressure; CD36 Antigens; Chemokine CXCL1; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Fibrosis; Fluorescent Dyes; HeLa Cells; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-1beta; Interleukin-6; Kidney; Male; Mice, Inbred C57BL; Mice, Knockout; Nephrectomy; NLR Family, Pyrin Domain-Containing 3 Protein; Peptides; Renal Insufficiency, Chronic; Ureteral Obstruction | 2016 |
Specific endothelial heparin-binding EGF-like growth factor deletion ameliorates renal injury induced by chronic angiotensin II infusion.
Topics: Albuminuria; Angiotensin II; Animals; Endothelium, Vascular; ErbB Receptors; Glomerulosclerosis, Focal Segmental; Heparin-binding EGF-like Growth Factor; Kidney; Mice; Mice, Knockout; Phosphorylation; Renal Insufficiency, Chronic | 2016 |
Endoplasmic reticulum stress inhibition attenuates hypertensive chronic kidney disease through reduction in proteinuria.
Topics: Angiotensin II; Animals; Apoptosis; Biopsy; Blood Pressure; Disease Models, Animal; Endoplasmic Reticulum Stress; Fibrosis; Gene Expression Profiling; Humans; Hypertension; Inflammation; Male; Mice; Mice, Knockout; Nephrosclerosis; Phenylbutyrates; Proteinuria; Renal Insufficiency, Chronic; Transcription Factor CHOP; Transcriptome; Urinalysis | 2017 |
FTY720 Attenuates Angiotensin II-Induced Podocyte Damage via Inhibiting Inflammatory Cytokines.
Topics: Adult; Angiotensin II; Animals; Cell Adhesion; Enzyme-Linked Immunosorbent Assay; Female; Fingolimod Hydrochloride; Humans; Immunohistochemistry; Interleukin-6; Lysophospholipids; Male; Middle Aged; Podocytes; Radioimmunoassay; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Renal Insufficiency, Chronic; Sphingosine; Tumor Necrosis Factor-alpha; Wound Healing; Young Adult | 2017 |
IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting.
Topics: Angiotensin II; Animals; Cell Line; Humans; Insulin Receptor Substrate Proteins; Interleukin-6; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Fibers, Skeletal; Muscular Atrophy; Proto-Oncogene Proteins c-akt; Rats; Receptors, Angiotensin; Recombinant Proteins; Renal Insufficiency, Chronic; Serum Amyloid A Protein; Suppressor of Cytokine Signaling Proteins; Wasting Syndrome | 2009 |
Renoprotective effect of Tanshinone IIA, an active component of Salvia miltiorrhiza, on rats with chronic kidney disease.
Topics: Abietanes; Administration, Oral; Angiotensin II; Animals; Collagen Type IV; Creatinine; Disease Models, Animal; Drugs, Chinese Herbal; Kidney; Male; Phenanthrenes; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Salvia miltiorrhiza; Transforming Growth Factor beta1 | 2010 |
Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage.
Topics: Adult; Angiotensin II; Animals; Biopsy; Blood Pressure; Disease Progression; Endothelin-1; Female; Fibrosis; Humans; Hypertension, Renal; Interleukin-6; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Middle Aged; Organ Culture Techniques; Proteinuria; Renal Insufficiency, Chronic; Signal Transduction; Vasoconstrictor Agents | 2012 |
AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
Topics: Albuminuria; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Dose-Response Relationship, Drug; Fumarates; Gene Expression; Kidney; Losartan; Male; Mice; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Treatment Outcome | 2012 |
An increase in perfusion pressure and activation of the renin-angiotensin system in the pathogenesis of hypertension and injury: strain vessels and the cerebrovascular-renal connection.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Blood Pressure; Cerebrovascular Circulation; Humans; Hypertension; Kidney; Rats; Renal Circulation; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2012 |
Association between the intrarenal renin-angiotensin system and renal injury in chronic kidney disease of dogs and cats.
Topics: Angiotensin II; Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Kidney; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System | 2013 |
Ang II induce kidney damage by recruiting inflammatory cells and up regulates PPAR gamma and Renin 1 gene: effect of β carotene on chronic renal damage.
Topics: Angiotensin II; Animals; Apolipoproteins E; beta Carotene; Cell Movement; Female; Inflammation; Kidney Glomerulus; Kidney Tubules, Proximal; Male; Mice; Mice, Knockout; Polycystic Kidney Diseases; PPAR gamma; Renal Insufficiency, Chronic; Renin | 2013 |
Beyond the RAAS: dissecting the antifibrotic effects of vitamin D analogues.
Topics: Angiotensin II; Animals; Fibrosis; Humans; Kidney; Mice; Mice, Knockout; Protective Agents; Renal Insufficiency, Chronic; Renin-Angiotensin System; Vitamin D | 2012 |